54 episodes

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

Treating Blood Cancers The Leukemia & Lymphoma Society

    • Science
    • 5.0 • 2 Ratings

Blood cancers are complex and multifaceted diseases, requiring knowledge by healthcare professionals on the array of diagnostic tests, treatment therapies, and survivorship issues. The LLS Podcast Series for Professionals provides up to date and accurate information on diagnosis, treatment and survivorship to educate HCPs treating patients with blood cancer. Listen in as we speak with experts who will guide us in understanding these topics, as well as address the importance of clinical trials, side effects management, and other concerns.

    2022 ASH Annual Meeting: Highlights from the Perspective of a Conference Attendee

    2022 ASH Annual Meeting: Highlights from the Perspective of a Conference Attendee

    Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

























    Recorded on December 19, 2022







    Lee Greenberger, PhD

    Chief Scientific Officer and SVP

    The Leukemia & Lymphoma Society

    Rye Brook, NY





    In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide an update on the information presented at the 64th American Society of Hematology (ASH) Annual Meeting, including leukemia, lymphoma, myeloma, MDS, and MPNs. Dr. Greenberger discusses updates in blood cancer therapies, including CAR T-cell therapy, bi-specific antibodies, and vaccine therapy, reviews the latest data on COVID-19, and addresses challenges that exist in diversity and equity in the healthcare system, including ways to overcome these barriers. Tune in today!

    • 33 min
    Understanding Waldenström Macroglobulinemia

    Understanding Waldenström Macroglobulinemia

    Shayna Sarosiek, MD, Dana Farber Cancer Institute, Boston, MA

























    Recorded on December 6, 2022







    Shayna Sarosiek, MD

    Assistant Professor

    Harvard Medical School

    Dana Farber Cancer Institute

    Boston, MA





    Waldenström Macroglobulinemia (WM) is a rare blood cell cancer characterized by an excess number of abnormal white blood cells in the bone marrow. How does WM fit into the spectrum of other blood cancer diseases? Who is at risk? What are the genetic factors? Dr. Shayna Sarosiek, from the Dana-Farber Cancer Institute, joins us to provide a deep dive into WM, including testing, monitoring, treatment updates, clinical trials, and so much more. Tune in today!











    This activity is developed through a collaboration with the International Waldenström’s Macroglobulinemia Foundation.

    • 34 min
    CAR T-cell Therapy in Review 2022: Updates in Treatment

    CAR T-cell Therapy in Review 2022: Updates in Treatment

    Sattva S. Neelapu, MD, M.D. Anderson Cancer Center, Houston, TX

























    Recorded on December 16, 2022







    Sattva S. Neelapu, MD

    Professor and Deputy Chair

    Department of Lymphoma and Myeloma

    The University of Texas M.D. Anderson Cancer Center

    Houston, TX





    Chimeric antigen receptor (CAR) T-cell therapy has generated impressive results in hematologic malignancies, with many drugs still in clinical trials. In this episode, Dr. Sattva S. Neelapu from MD Anderson Cancer Center, joins us to discuss updates on CAR T-cell therapy from the 2022 American Society of Hematology (ASH) Annual Meeting. Dr. Neelapu also provides a high-level overview of how CAR T-cell therapy works, including the manufacturing process, and discusses the risk of recurrence following therapy, risk for patients in the era of COVID-19, secondary cancers, associated costs, roadblocks to therapy, and why early referral matters. Tune in to this informative podcast episode to learn more!











    This podcast episode is supported by Allogene Therapeutics, Bristol Myers Squibb, CRISPR Therapeutics, Janssen Oncology & Legend Biotech, Kite, A Gilead Company and Novartis Oncology.

    • 32 min
    Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part II

    Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part II

    Daphne Friedman, MD, Durham VA Health Care System, Durham, NC

























    Recorded on October 20, 2022







    Daphne Friedman, MD

    Staff Oncologist, Durham VA Health Care System

    Associate Professor, Duke University School of Medicine

    Durham, NC





    In Part II of Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia, Dr. Daphne Friedman, from the Durham VA Health Care System in North Carolina, discusses the importance of a relationship between the provider and the patient when it comes to shared decision making (SDM), including the unique conversations of SDM with young adults and with healthcare providers who are patients. Dr. Friedman also shares challenges with seeking a second opinion, relying on information found on the internet, and additional resources. Tune in today to learn more!











    This podcast episode is supported by AbbVie Inc. and Genentech, Inc.

    • 27 min
    AML: Insights, Updates, and Takeaways

    AML: Insights, Updates, and Takeaways

    Eytan M. Stein, MD, Memorial Sloan Kettering Cancer Center, New York, NY

























    Recorded on October 7, 2022







    Eytan M. Stein, MD

    Chief, Leukemia Service

    Director, Program for Drug Development in Leukemia

    Associate Attending Physician

    Leukemia Service, Department of Medicine

    Memorial Sloan Kettering Cancer Center

    New York, NY





    Dr. Eytan Stein, from Memorial Sloan Kettering Cancer Center, joins us to reflect on breakthroughs in acute myeloid leukemia, including updates in treatment, long-term and late effects of therapy, and side effect management. Tune in to this episode as Dr. Stein discusses an overview of data presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) as well as updates from The Leukemia & Lymphoma Society’s BEAT AML® Master Trial.

    • 25 min
    Insights from Attending the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting

    Insights from Attending the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting

    Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY

























    Recorded on September 30, 2022







    Saad Z. Usmani, MD, MBA, FACP

    Hematologic Oncologist

    Chief, Myeloma Service

    Memorial Sloan Kettering Cancer Center

    New York, NY





    Join us for this special episode, recorded live from the Tenth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of Professional Education and Engagement at The Leukemia & Lymphoma Society, speaks with Dr. Saad Usmani, from Memorial Sloan Kettering Cancer Center, about his insights into the progress in immunotherapies in blood cancers shared at the conference. Not able to attend SOHO? Learn more about what was shared at the conference by tuning in here! 

    • 16 min

Customer Reviews

5.0 out of 5
2 Ratings

2 Ratings

Top Podcasts In Science

Hidden Brain, Shankar Vedantam
Alie Ward
Neil deGrasse Tyson
Jeremy Corbell, George Knapp, Cadence13 and Dark Horse Entertainment
CBC Radio
PRX and Greater Good Science Center

You Might Also Like

Dr Neil Love
Vinay Prasad, MD MPH
Hidden Brain, Shankar Vedantam
American Society of Hematology
The Curbsiders Internal Medicine Podcast
Pushkin Industries